Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia

被引:0
|
作者
Yoji Ishida
Kazunori Murai
Kohei Yamaguchi
Takuto Miyagishima
Motohiro Shindo
Kazuei Ogawa
Takahiro Nagashima
Shinji Sato
Reiko Watanabe
Satoshi Yamamoto
Takayuki Hirose
Souich Saitou
Masakatsu Yonezumi
Takeshi Kondo
Yuichi Kato
Noboru Mochizuki
Keiko Ohno
Satoshi Kishino
Kohmei Kubo
Tatsuo Oyake
Shigeki Ito
机构
[1] Iwate Medical University School of Medicine,Saitama Medical Center
[2] Aomori Prefectural Central Hospital,Department of Hematology and Oncology, Internal Medicine
[3] Kushiro Rosai Hospital,undefined
[4] Asahikawa Medical University School of Medicine,undefined
[5] Fukushima Medical University School of Medicine,undefined
[6] Kitami Red Cross Hospital,undefined
[7] Okitama Public General Hospital,undefined
[8] Saitama Medical University,undefined
[9] Sapporo City General Hospital,undefined
[10] Niigata Cancer Center Hospital,undefined
[11] Nihonkai General Hospital,undefined
[12] Hokkaido Cancer Center,undefined
[13] Hokkaido University School of Medicine,undefined
[14] Yamagata University Faculty of Medicine,undefined
[15] Meiji Pharmaceutical University,undefined
[16] Iwate Medical University School of Medicine,undefined
关键词
Dasatinib; Phamacokinetics; Pharmacodynamics; Molecular response; Half maximal inhibitory concentration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:185 / 193
页数:8
相关论文
共 50 条
  • [21] Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia
    周励
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (02) : 123 - 123
  • [22] A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia
    Radich, Jerald P.
    Kopecky, Kenneth J.
    Appelbaum, Frederick R.
    Kamel-Reid, Suzanne
    Stock, Wendy
    Malnassy, Greg
    Paietta, Elisabeth
    Wadleigh, Martha
    Larson, Richard A.
    Emanuel, Peter
    Tallman, Martin
    Lipton, Jeff
    Turner, A. Robert
    Deininger, Michael
    Druker, Brian J.
    BLOOD, 2012, 120 (19) : 3898 - 3905
  • [23] Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
    Chuah, Charles T.
    Nakamae, Hirohisa
    Shen, Zhixiang X.
    Bradley-Garelik, M. Brigid
    Kim, Dong-Wook
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2093 - 2100
  • [24] Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)
    Naqvi, Kiran
    Cortes, Jorge E.
    Skinner, Jeffrey
    Jabbour, Elias J.
    Pemmaraju, Naveen
    Bose, Prithviraj
    Thompson, Philip A.
    Borthakur, Gautam
    Estrov, Zeev
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [25] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Gambacorti-Passerini, Carlo
    Piazza, Rocco
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2274 - 2276
  • [26] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (10): : 885 - 898
  • [27] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [28] Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phase
    Atallah, Ehab
    Cortes, Jorge
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 138 - 144
  • [29] Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007
    Mughal, Tariq
    Goldman, John M.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S95 - S101
  • [30] Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome
    Freydman, Jessica
    Staron, Andrew
    Hughes, David
    Sloan, John M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1489 - 1493